A gel that could help the cervix heal from HPV?

NCT ID NCT07762209

Not yet recruiting Disease control Sponsor: Hifas da Terra S.L. Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial is testing whether a vaginal gel called Papilozumib, used alone or with an oral supplement, can help restore the cervical lining in women aged 30 to 50 who have an HPV infection. Participants will be randomly assigned to receive the gel, the gel plus supplement, or standard care, and will be followed for six months. The main goal is to see if the gel improves cervical tissue healing, with additional checks on HPV clearance and vaginal health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Papilozumib vaginal gel, with or without an oral supplement containing mushroom extracts, vitamins, minerals, and probiotics
What this could lead to: If effective, this gel could offer a non-invasive way to help the cervix heal and potentially clear HPV, reducing the risk of cervical abnormalities.
What could go wrong: This is an early exploratory trial with a small number of participants, so results may not be conclusive. The gel's effect on HPV clearance is uncertain, and it may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Atypical Squamous Cells of the Cervix human papilloma virus infection Squamous Intraepithelial Lesions

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HUMAN PAPILLOMAVIRUS INFECTION HUMAN PAPILLOMAVIRUS INFECTIONS

Contacts and locations

Locations

Consulta Privada Miguel Ángel Rodríguez Zambrano

Majadahonda, Madrid, 28220, Spain
Ginegetafe

Getafe, Madrid, 28901, Spain
Hospital HM Montepríncipe

Boadilla del Monte, Madrid, 28660, Spain
Hospital Quirónsalud Valle del Henares

Torrejón de Ardoz, Madrid, 28850, Spain
Hospital Universitario Sanitas La Moraleja - Edificio Ana de Austria

Hortaleza, Madrid, 28050, Spain
Instituto Palacios, Salud y Medicina de la Mujer

Madrid, Madrid, 28009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.